Founder Friendly Investors
Pilot Growth News - Page 5 of 13 - Pilot Growth Equity

Pilot Growth News

The Software Report

The Top 50 SaaS CEOs of 2019

We are pleased to announce The Software Report’s third annual Top 50 SaaS CEOs awards.  In 2019, we received an astounding number of nomination submissions that provided meaningful insight into the inner workings of some of today’s most successful SaaS

Read more »
Homeland Prep News

New index offers tool to monitor global disease outlook

A new global index offers an original way to monitor national-level preparedness for infectious disease, providing a holistic view of a country’s capacity to mitigate the spread of illness and pandemics. Created by researchers at Metabiota, the Epidemic Preparedness Index (EPI)

Read more »
Oxbow Partners

Oxbow Partners Names Metabiota as a Top 25 Insurtech Company for 2019

Epidemic risk is a major threat. In the last decade, there have been over 400 high-priority human disease outbreaks which have impacted the stability of economies and corporations. The Zika virus alone may end up costing Latin America and the Caribbean up to $18bn, and the South Korean MERS outbreak in 2015 caused a 40% drop in tourism, leading to an estimated $900m drop in revenue.

Metabiota has created a comprehensive and objective methodology for quantifying the potential impact of epidemic risk. The company’s methodology comprises both data experts and on-the-ground specialists. It provides underwriters with tools to analyse and quantify the financial impact of epidemics for use in their underwriting processes. Separately, it works with industry (e.g. sports clubs) to understand the impact of epidemics on their businesses.

Read more »
PR.com

Perthera Announces Appointment of Gary Gregory as CEO, President, and Board Member

Perthera, Inc., the leading cancer therapeutic intelligence company, announced that Gary L. Gregory has joined the company as its Chief Executive Officer, President and Board Member.

Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts.

Read more »